DHRS4 and prostate adenocarcinoma: Moreover, we have also checked the expression level of DHRS4-AS1 by GEPIA tool and obtained the same result (Figure 5C) and performed overall survival analysis of DHRS4-AS1 in PRAD, and results showed that high expression groups have poor survival (Figure 5D).